FR2499429B1 - Procede pour reduire les pyrogenes dans une substance qu'ils contaminent - Google Patents

Procede pour reduire les pyrogenes dans une substance qu'ils contaminent

Info

Publication number
FR2499429B1
FR2499429B1 FR8202042A FR8202042A FR2499429B1 FR 2499429 B1 FR2499429 B1 FR 2499429B1 FR 8202042 A FR8202042 A FR 8202042A FR 8202042 A FR8202042 A FR 8202042A FR 2499429 B1 FR2499429 B1 FR 2499429B1
Authority
FR
France
Prior art keywords
pyrogens
contaminate
substance
reducing
reducing pyrogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8202042A
Other languages
English (en)
Other versions
FR2499429A1 (fr
Inventor
Ichiro Chibata
Tetsuya Tosa
Tadashi Sato
Taizo Watanabe
Satoshi Minobe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of FR2499429A1 publication Critical patent/FR2499429A1/fr
Application granted granted Critical
Publication of FR2499429B1 publication Critical patent/FR2499429B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B01J20/3255—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising a cyclic structure containing at least one of the heteroatoms nitrogen, oxygen or sulfur, e.g. heterocyclic or heteroaromatic structures
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/02—Alkyl or cycloalkyl ethers
    • C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/14—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0039—Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR8202042A 1981-02-10 1982-02-09 Procede pour reduire les pyrogenes dans une substance qu'ils contaminent Expired FR2499429B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8103972 1981-02-10

Publications (2)

Publication Number Publication Date
FR2499429A1 FR2499429A1 (fr) 1982-08-13
FR2499429B1 true FR2499429B1 (fr) 1987-10-02

Family

ID=10519568

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8202042A Expired FR2499429B1 (fr) 1981-02-10 1982-02-09 Procede pour reduire les pyrogenes dans une substance qu'ils contaminent

Country Status (5)

Country Link
US (1) US4381239A (fr)
JP (2) JPS57183712A (fr)
DE (1) DE3204544A1 (fr)
FR (1) FR2499429B1 (fr)
SE (1) SE461505B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4488969A (en) * 1982-02-09 1984-12-18 Amf Incorporated Fibrous media containing millimicron-sized particulates
JPS58170506A (ja) * 1982-03-30 1983-10-07 Sumitomo Chem Co Ltd 変異原性物質の処理法
US4596660A (en) * 1982-07-23 1986-06-24 Amf Inc. Fibrous media containing millimicron-sized particulates
US4677194A (en) * 1985-08-09 1987-06-30 Biotech Research Laboratories, Inc. Isolation of an endotoxin inactivator from human plasma
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US5955581A (en) * 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5753616A (en) * 1986-11-10 1998-05-19 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
JPH01127039A (ja) * 1987-11-10 1989-05-19 Chuichi Hirayama 発熱物質吸着体
JP2577237B2 (ja) * 1988-02-05 1997-01-29 雪印乳業株式会社 樹脂担体からパイロジェンを除去する方法
US5342785A (en) * 1988-07-05 1994-08-30 Tanabe Seiyaku Co., Ltd. Method for determining pyrogen content
JP2524406B2 (ja) * 1988-07-05 1996-08-14 田辺製薬株式会社 パイロジェン定量方法
JPH02104518A (ja) * 1988-10-13 1990-04-17 Tosoh Corp 発熱性物質の除去方法
US5085780A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US5085784A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US4981591A (en) * 1989-04-07 1991-01-01 Cuno, Incorporated Cationic charge modified filter media
AU6428390A (en) * 1989-08-16 1991-04-03 Rorer International (Overseas) Inc. Treatment of immobilized matrices with antimicrobial agents to remove pyrogen-producing organisms and pyrogens
US5202246A (en) * 1989-08-16 1993-04-13 Armour Pharmaceutical Company Treatment of immobilized matrices for preparation of pharmaceutical and biological products with anti-microbial agents to remove pyrogen-producing organisms and pyrogens
AU6441490A (en) * 1989-09-18 1991-04-18 Cuno Incorporated Filter media and use for pyrogen removal
US5169535A (en) * 1989-09-22 1992-12-08 Kurita Water Industries Ltd. Method of removing endotoxin
JPH0687974B2 (ja) * 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
DK52791D0 (da) * 1991-03-22 1991-03-22 Kem En Tec As Adsorptionsmatricer
DE4113602A1 (de) * 1991-04-23 1992-10-29 Falkenhagen Dieter Dr Sc Med Endotoxinadsorber und verfahren zu seiner herstellung
DE4331358A1 (de) * 1992-10-12 1994-04-14 Braun Melsungen Ag Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten
FR2701948B1 (fr) * 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
WO1995031727A1 (fr) * 1994-05-13 1995-11-23 Therasorb Medizinische Systeme Gmbh Colonne sterile et apyrogene couplee a une proteine en vue de la fixation et de l'extraction de substances donnees du sang
US5502022A (en) * 1994-05-16 1996-03-26 Biosepra, Inc. Chromatography adsorbents utilizing mercapto heterocyclic ligands
US6150507A (en) * 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
GB9910807D0 (en) * 1999-05-10 1999-07-07 Prometic Biosciences Limited Novel detoxification agents and their use
US6585890B2 (en) 2000-02-04 2003-07-01 Applied Research Associates, Inc. Process for producing sterile water for injection from potable water
EP1292337A2 (fr) * 2000-06-08 2003-03-19 La Jolla Pharmaceutical Molecules a plate-forme polyvalentes comprenant un poly(ethylene oxyde) de poids moleculaire eleve
AU2002258734A1 (en) * 2001-04-13 2002-10-28 Wyeth Holdings Corporation Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
US7122149B2 (en) * 2002-07-12 2006-10-17 Applied Research Associates, Inc. Apparatus and method for continuous depyrogenation and production of sterile water for injection
US7045366B2 (en) * 2003-09-12 2006-05-16 Ciphergen Biosystems, Inc. Photocrosslinked hydrogel blend surface coatings
US20060292701A1 (en) * 2002-09-13 2006-12-28 Ciphergen Biosystems Inc. Photocrosslinked hydrogel blend surface coatings
WO2004024318A1 (fr) * 2002-09-13 2004-03-25 Pall Corporation Preparation et utilisation de substrats solides en mode mixte pour adsorbants en chromatographie et reseaux de biopuces
US20050272917A1 (en) * 2004-05-14 2005-12-08 Hematech, Llc Methods for immunoglobulin purification
US20080033162A1 (en) * 2004-06-28 2008-02-07 Akzo Nobel N.V. Water-Soluble Cellulose Derivative Comprising A Ligand
EP1796832A1 (fr) * 2004-09-01 2007-06-20 Cobento A/S Procedes de purification de molecules contenant de la corrine
EP2570182A1 (fr) * 2011-09-15 2013-03-20 InstrAction GmbH Sorbant comportant à sa surface un résidu aliphatique cationique ou protonisable pour la purification de molécules organiques
WO2015005361A1 (fr) * 2013-07-08 2015-01-15 国立大学法人京都工芸繊維大学 Agent de séparation
JP2016098313A (ja) * 2014-11-21 2016-05-30 セイコーエプソン株式会社 セルロース系材料、液状組成物、造形物および造形物の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4856770A (fr) * 1971-11-10 1973-08-09
DE2319495C2 (de) * 1973-04-17 1985-01-10 Yeda Research And Development Co., Ltd., Rehovot Verfahren zum selektiven, reversiblen Binden von Biomolekülen an ein Adsorbens in einer chromatographischen Säule
US3959128A (en) * 1974-12-27 1976-05-25 Preventive Systems, Inc Process for removing endotoxin from biological fluids
US4059512A (en) * 1974-12-27 1977-11-22 Preventive Systems, Inc. Process for removing endotoxin from biological fluids
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
US4090919A (en) * 1976-01-29 1978-05-23 Tanabe Seiyaku Co., Ltd. Water-insoluble tannin preparation for immobilization of proteins
JPS52102414A (en) * 1976-02-25 1977-08-27 Puribenteibu Shisuteimuzu Inc Removement of endotoxin from biological fluid
US4321363A (en) * 1980-02-21 1982-03-23 Nippon Soda Company Limited Adsorbent for urokinase containing agarose

Also Published As

Publication number Publication date
JPS57183712A (en) 1982-11-12
JPH0214325B2 (fr) 1990-04-06
SE461505B (sv) 1990-02-26
FR2499429A1 (fr) 1982-08-13
DE3204544C2 (fr) 1990-07-12
JPS63118301A (ja) 1988-05-23
US4381239A (en) 1983-04-26
SE8200715L (sv) 1982-08-11
DE3204544A1 (de) 1982-09-02
JPH037681B2 (fr) 1991-02-04

Similar Documents

Publication Publication Date Title
FR2499429B1 (fr) Procede pour reduire les pyrogenes dans une substance qu'ils contaminent
FR2517881B1 (fr) Procede de formation d'elements de taille inferieure au micron dans des dispositifs a semi-conducteur
FR2572406B1 (fr) Procede pour la preparation d'acides diphosphoniques
RO88641A (fr) Procede pour la preparation du l'ethylenglycole
FR2551583B1 (fr) Procede d'attaque selective de materiaux dans les dispositifs semi-conducteurs
PT75499A (fr) Procede pour la preparation de l'alkanoilanilides
RO86859A (fr) Procede pour la preparation d'un biester du methanediole
FR2542495B1 (fr) Procede pour l'incorporation de boues dans du cimentÿa
RO83840A2 (fr) Procede pour la preparation des acides alpha-arylalcanoiques
FR2555186B1 (fr) Procede pour la fabrication d'une polyetheresteramide
FR2550954B1 (fr) Procede de degazage d'un liquide
FR2547894B1 (fr) Procede permettant d'etancher les tuyaux
BE892808A (fr) Procede pour la decomposition d'alkyl-tert-alkyl-ethers
FR2502626B1 (fr) Acides oxazaphosphorin-4-thio-alcanesulfoniques, leurs sels neutres, procede pour leur preparation et preparations pharmaceutiques qui les contiennent
FR2515212B1 (fr) Procede pour affiner l'or
RO83099A (fr) Procede pour la preparation d'une pyrrolidinone
RO92200A (fr) Procede pour la preparation des s-benzylcarbamates
MA19421A1 (fr) Procede pour la purification de solutions acides contenant de l'URANIUM
FR2503713B1 (fr) 2,3-di-substitue-5,6-dihydro-imidazo-(2,1-b) thiazoles, procede pour leur preparation et agents anti-inflammatoires les contenant
RO85386A (fr) Procede pour la purification des derives d'acides phenoxybenzoiques
RO85812A (fr) Procede pour la preparation des derives d'azolylpentene
FR2548654B1 (fr) Procede pour la separation de l'arsenic des solutions acides qui en contiennent
BE896217A (fr) Liposomes et procede pour les preparer
RO84278A (fr) Procede pour la preparation des derives de l'acide penycilanique
RO89437A (fr) Procede pour la preparation d'une forme galenique de sulpyride

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse